Related Experiment Video
Updated: Jan 27, 2026
07:29
Author Spotlight: Exploring the Mechanisms of MicroRNA Loading into Extracellular Vesicles in Cancer Progression
Published on: October 6, 2023
2.0K
Nanocapsules for Programmed Neurotransmitter Release: Toward Artificial Extracellular Synaptic Vesicles
Keitaro Sou1, Duc Long Le2, Hirotaka Sato2
1Research Institute for Science and Engineering, Waseda University, 3-4-1 Ohkubo, Shinjuku, Tokyo, 169-8555, Japan.
Small (Weinheim an Der Bergstrasse, Germany)
|March 20, 2019
Summary
Stimulus-responsive nanocapsules offer precise control over chemical and biomolecule release for targeted biological action. This technology shows potential for developing artificial synaptic vesicles to treat nervous system disorders.
Area of Science:
- Biotechnology
- Nanotechnology
- Neuroscience
Background:
- Nanocapsules are effective for delivering chemicals and biomolecules.
- Controlled release mechanisms are crucial for targeted therapeutic action.
- Signal transduction in biological systems can be modulated by molecule release.
Purpose of the Study:
- To explore nanocapsules as tools for spatiotemporal control of signal transduction.
- To investigate stimulus-responsive nanocapsules for programmed payload release.
- To assess the potential of neurotransmitter-encapsulating nanocapsules as artificial extracellular synaptic vesicles.
Main Methods:
- Development of stimulus-responsive nanocapsules.
- Encapsulation of signaling molecules, including neurotransmitters.
- Investigation of payload release mechanisms triggered by external stimuli.
Main Results:
- Nanocapsules enable blocked biological action until triggered release.
- Stimulus-responsive systems allow for programmed payload delivery.
- Potential for precise spatiotemporal control of molecular release.
Conclusions:
- Nanocapsules offer a platform for targeted delivery and controlled release of biomolecules.
- Stimulus-responsive nanocapsules are key to achieving programmed release.
- This technology may lead to novel therapeutic strategies for neuromodulation and nervous system disorders.
Related Concept Videos
01:12Synaptic Signaling
79.3K
Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
79.3K
01:09Synaptic Signaling
6.6K
Neurons communicate at synapses, or junctions, to excite or inhibit the activity of other neurons or target cells, such as muscles. Synapses may be chemical or electrical.
Most synapses are chemical, meaning an electrical impulse or action potential spurs the release of chemical messengers called neurotransmitters. The neuron sending the signal is called the presynaptic neuron, and the neuron receiving the signal is the postsynaptic neuron.
The presynaptic neuron fires an action potential that...
Most synapses are chemical, meaning an electrical impulse or action potential spurs the release of chemical messengers called neurotransmitters. The neuron sending the signal is called the presynaptic neuron, and the neuron receiving the signal is the postsynaptic neuron.
The presynaptic neuron fires an action potential that...
6.6K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
886
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
886
01:30Neurotransmitters
5.1K
Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...
5.1K
01:31Neurotransmitters
2.7K
Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
2.7K